Bank Julius Baer & Co. Ltd, Zurich Co Diagnostics, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$7.16 - $9.56 $524,634 - $700,489	-73,273 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$8.52 - $19.21 $834,193 - $1.88 Million	-97,910 Reduced 57.2%	73,273 $699,000
Q4 2020 Feb 24, 2021	BUY	$9.3 - $15.19 $1.46 Million - $2.39 Million	157,409 Added 1142.8%	171,183 $1.59 Million
Q4 2020 Feb 12, 2021	SELL	$9.3 - $15.19 $89,521 - $146,218	-9,626 Reduced 41.14%	13,774 $1.59 Million
Q3 2020 Nov 10, 2020	BUY	$8.24 - $30.8 $187,048 - $699,160	22,700 Added 3242.86%	23,400 $318,000
Q2 2020 Aug 12, 2020	SELL	$7.46 - $23.42 $5,259 - $16,511	-705 Reduced 50.18%	700 $14,000
Q1 2020 May 13, 2020	BUY	$0.91 - $17.81 $1,278 - $25,023	1,405 New	1,405 $11,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $26.3M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.